Annika Filip

Annika completed her Bachelor of Science in Molecular and Cellular Biology at Oregon State University followed by a Master of Science in Molecular Biomedicine at the Heinrich-Heine-Universität Düsseldorf. Her master thesis revolved around the targeted degradation of the ETV6::RUNX1 fusion gene using HaloPROTAC3s in the context of pediatric B-ALL. Since joining the Müschen Lab, she has focused on developing iPSC-derived B-cell development models.